Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals DRC | B3 | Salute | Ricerca medica e biotecnologica | 727,99 Mrd BRL | -250,9x | 2,2 | 705,27 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron | B3 | Salute | Ricerca medica e biotecnologica | 494,80 Mrd BRL | 17,5x | 1,13 | 76,08 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
IQVIA Holdings BDR | B3 | Salute | Ricerca medica e biotecnologica | 219,09 Mrd BRL | 26,3x | 0,96 | 300,40 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioNTech SE | B3 | Salute | Ricerca medica e biotecnologica | 170,87 Mrd BRL | -57,6x | 0,49 | 45,16 BRL | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beigene | B3 | Salute | Ricerca medica e biotecnologica | 132,43 Mrd BRL | -24,5x | -1,68 | 50,20 BRL | -2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Moderna | B3 | Salute | Ricerca medica e biotecnologica | 100,98 Mrd BRL | -7,6x | -0,21 | 13,11 BRL | -2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioTechne | B3 | Salute | Ricerca medica e biotecnologica | 71,87 Mrd BRL | 79,1x | -2,18 | 13,08 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ascendis Pharma AS | B3 | Salute | Ricerca medica e biotecnologica | 48,33 Mrd BRL | -17,2x | -0,59 | 55 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biomm On | B3 | Salute | Ricerca medica e biotecnologica | 1,05 Mrd BRL | -13,2x | -0,37 | 8,24 BRL | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |